Holen Sie sich die Stockscreener-App
24.52
0.85%
-0.21
Handel nachbörslich:
24.57
0.05
+0.20%
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt PFE?
Forum
Prognose
Aktiensplit
Dividendenhistorie
Pfizer Inc Aktie (PFE) Neueste Nachrichten
Lobbying Update: $30,000 of PFIZER INC. lobbying was just disclosed - Quiver Quantitative
Pfizer (PFE) Faces Continued Losses Despite Bullish Analyst Rati - GuruFocus
Is Pfizer’s Latest Drug Pricing Deal a Turning Point for 2025 Valuation? - simplywall.st
Pfizer (PFE) Receives a Buy from BMO Capital - The Globe and Mail
Pfizer Seeks Expanded Use Approval For Breast Cancer Drug - Benzinga
Pfizer's (PFE) Tukysa Achieves Key Milestone in Breast Cancer Tr - GuruFocus
Pfizer (PFE) Receives a Hold from Bernstein - The Globe and Mail
Pfizer succeeds in late-stage trial for Tukysa breast cancer drug as maintenance therapy - Seeking Alpha
Pfizer (PFE) Reports Positive Results from Key Breast Cancer Tri - GuruFocus
Pfizer Says Tukysa Combination as First-Line Maintenance Meets Main Goal in Breast Cancer Trial - MarketScreener
Tukysa combination significantly improves progression-free survival as first-line maintenance in HER2+ metastatic breast cancer in HER2CLIMB-05 trial - MarketScreener
Traws Pharma Doses First Patient with Ratutrelvir in Phase 2 COVID Studies, Expects Results by Year-End 2025 - GlobeNewswire Inc.
Pfizer’s breast cancer drug shows promise in first-line treatment - Investing.com
Pfizer’s breast cancer drug shows promise in first-line treatment By Investing.com - Investing.com India
Day 6 of Loss Streak for Pfizer Stock with -9.6% Return (vs. -1.8% YTD) [10/13/2025] - Trefis
Pfizer’s (PFE) Pipeline and Dividend Yield Make it a Compelling Income Stock - Yahoo Finance
Trump's AstraZeneca Deal Echoes Pfizer Pact. Big Pharma's Political Headaches Are Easing. - Barron's
AZN Strikes Drug Pricing Deal With Trump, Gets 3-Year Tariff Reprieve - The Globe and Mail
Pfizer Reaches Agreement with U.S. Government to Lower Drug Costs - Contract Pharma
Lawsuits Claim Pfizer Failed to Warn of Brain Tumor Risk From Birth Control Shot - Truthout
Trump Secures Major Win as AstraZeneca Joins Pfizer in Lowering US Drug Prices - Medical Daily
Global markets live: Blackstone, Pfizer, Tesla, Stellantis, AstraZeneca… - MarketScreener
Pfizer stock rises as BMO Capital reiterates Outperform rating - Investing.com
How Pfizer Inc. (PFE) Affects Rotational Strategy Timing - news.stocktradersdaily.com
Investors Heavily Search Pfizer Inc. (PFE): Here is What You Need to Know - Yahoo Finance
IP Group shares fly on back of Metsera & Pfizer news - BusinessCloud
Verdence Capital Advisors LLC Increases Stake in Pfizer Inc. $PFE - MarketBeat
Pfizer To Highlight Advancements In Respiratory Health And Infectious Disease Research At IDWeek 2025 - TradingView
Griffin Asset Management Inc. Grows Holdings in Pfizer Inc. $PFE - MarketBeat
Pfizer to present infectious disease data at IDWeek 2025 - Investing.com
Concurrent Investment Advisors LLC Purchases 20,663 Shares of Pfizer Inc. $PFE - MarketBeat
Pfizer to Highlight Advancements in Respiratory Health and Infectious Disease Research at IDWeek 2025 - Business Wire
Vanguard Personalized Indexing Management LLC Grows Position in Pfizer Inc. $PFE - MarketBeat
Pfizer, Inc. (PFE) Stock Analysis: Exploring the 16% Upside Potential and Robust Dividend Yield - DirectorsTalk Interviews
Estrogen Blockers Market Is Booming Worldwide 2025-2032 | Pfizer Inc., Novartis AG, AstraZeneca PLC - openPR.com
IP Group in line for future royalties from Pfizer’s drug deal - Proactive Investors
FY2025 EPS Estimates for Pfizer Lowered by Cantor Fitzgerald - MarketBeat
Is Pfizer (NYSE:PFE) Using Too Much Debt? - Yahoo Finance
Cwm LLC Raises Stake in Pfizer Inc. $PFE - MarketBeat
Sippican Capital Advisors Has $2.25 Million Stock Holdings in Pfizer Inc. $PFE - MarketBeat
Means Investment CO. Inc. Sells 22,379 Shares of Pfizer Inc. $PFE - MarketBeat
Callan Family Office LLC Purchases 48,269 Shares of Pfizer Inc. $PFE - MarketBeat
Pfizer Inc. (NYSE: PFE) Price Prediction and Forecast 2025-2030 (October 2025) - 24/7 Wall St.
Pfizer (PFE) Faces Challenges Amid Drug Pricing Push - GuruFocus
LaRuby May and team of attorneys file suit against Pfizer, claim negligence in premature release of sickle cell drug therapy - AFRO American Newspapers
Precision Trading with Pfizer Inc. (PFE) Risk Zones - news.stocktradersdaily.com
Pfizer's Deal on Drug Prices Gets Closer to the Right Idea - Advisor Perspectives
Guggenheim Keeps Their Buy Rating on Pfizer (PFE) - The Globe and Mail
Pfizer Inc. $PFE Shares Bought by Fifth Third Wealth Advisors LLC - MarketBeat
Drucker Wealth 3.0 LLC Sells 15,443 Shares of Pfizer Inc. $PFE - MarketBeat
Aberdeen Group plc Increases Position in Pfizer Inc. $PFE - MarketBeat
Pfizer Inc. | Pharmaceuticals, Vaccines & Company History | Britannica Money - Britannica
Pfizer (NYSE:PFE) Trading Down 1.7%What's Next? - MarketBeat
Pfizer (PFE) Target Price Lowered by Morgan Stanley | PFE Stock News - GuruFocus
Next medicine deal after Pfizer? Analysts, shares point to AstraZeneca, Eli Lilly - WHTC
FDA Gives Tentative Nod to Sandoz's Generic Version of Pfizer's Inlyta - GuruFocus
Sandoz granted tentative approval for generic of Pfizer's Inlyta - Seeking Alpha
Pfizer's Q3: The Catalyst For A Bullish Resurgence (Earnings Preview) (PFE) - Seeking Alpha
Dividend Roundup: Lockheed Martin, Pfizer, Genpact, Delta Air Lines, and more (SCHD:NYSEARCA) - Seeking Alpha
JB Capital LLC Reduces Position in Pfizer Inc. $PFE - MarketBeat
Saudi Arabia Adult Vaccine Market Forecast Report 2025-2033 Featuring Company Analysis and Vaccine Sales of GlaxoSmithKline, AstraZeneca, Sanofi Pasteur, Pfizer, CSL LimitedResearchAndMarkets.com - Business Wire
Commerzbank Aktiengesellschaft FI Purchases 83,531 Shares of Pfizer Inc. $PFE - MarketBeat
Morgan Stanley Adjusts Price Target on Pfizer to $32 From $33, Maintains Equalweight Rating - MarketScreener
Pfizer Inc. $PFE Holdings Boosted by Coerente Capital Management - MarketBeat
Blair William & Co. IL Reduces Stock Holdings in Pfizer Inc. $PFE - MarketBeat
Vontobel Holding Ltd. Purchases 14,808 Shares of Pfizer Inc. $PFE - MarketBeat
First Merchants Corp Decreases Stock Holdings in Pfizer Inc. $PFE - MarketBeat
Maryland State Retirement & Pension System Buys 10,986 Shares of Pfizer Inc. $PFE - MarketBeat
0.23%
1.46%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):